Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Leroux

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cephalalgia : an International Journal of Headache|December 1, 2012
Use of cannabis among 139 cluster headache sufferersElizabeth Leroux, Irina Taifas, Dominique Valade, et al.
Headache|September 16, 2017
A Nursing Intervention Increases Quality of Life and Self-Efficacy in Migraine: A 1-Year Prospective Controlled TrialElizabeth Leroux, Line Beaudet, Guy Boudreau, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 15, 2020
Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN)Janet Ford, Cristina Tassorelli, Elizabeth Leroux, et al.
The Lancet. Neurology|September 10, 2011
Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trialElizabeth Leroux, Dominique Valade, Irina Taifas, et al.
Advances in Therapy|September 29, 2020
Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature ReviewElizabeth Leroux, Andrew Buchanan, Louise Lombard, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
Canadian Headache Society Guideline: acute drug therapy for migraine headacheIrene Worthington, Tamara Pringsheim, Marek J Gawel, et al.
Neuromodulation : Journal of the International Neuromodulation Society|November 28, 2017
Neurostimulation for Refractory Cervicogenic Headache: A Three-Year Retrospective StudyMarzieh Eghtesadi, Elizabeth Leroux, Marie-Pierre Fournier-Gosselin, et al.
Neurology|July 5, 2019
Two randomized migraine studies of galcanezumab: Effects on patient functioning and disabilityJanet H Ford, David W Ayer, Qi Zhang, et al.
The Journal of Headache and Pain|November 8, 2023
Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International StudyRichard B Lipton, Michel Lanteri-Minet, Elizabeth Leroux, et al.
Cephalalgia : an International Journal of Headache|August 23, 2024
Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) StudyZaza Katsarava, Dawn C Buse, Elizabeth Leroux, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cephalalgia : an International Journal of Headache|December 1, 2012
Use of cannabis among 139 cluster headache sufferersElizabeth Leroux, Irina Taifas, Dominique Valade, et al.
Headache|September 16, 2017
A Nursing Intervention Increases Quality of Life and Self-Efficacy in Migraine: A 1-Year Prospective Controlled TrialElizabeth Leroux, Line Beaudet, Guy Boudreau, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 15, 2020
Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN)Janet Ford, Cristina Tassorelli, Elizabeth Leroux, et al.
The Lancet. Neurology|September 10, 2011
Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trialElizabeth Leroux, Dominique Valade, Irina Taifas, et al.
Advances in Therapy|September 29, 2020
Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature ReviewElizabeth Leroux, Andrew Buchanan, Louise Lombard, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
Canadian Headache Society Guideline: acute drug therapy for migraine headacheIrene Worthington, Tamara Pringsheim, Marek J Gawel, et al.
Neuromodulation : Journal of the International Neuromodulation Society|November 28, 2017
Neurostimulation for Refractory Cervicogenic Headache: A Three-Year Retrospective StudyMarzieh Eghtesadi, Elizabeth Leroux, Marie-Pierre Fournier-Gosselin, et al.
Neurology|July 5, 2019
Two randomized migraine studies of galcanezumab: Effects on patient functioning and disabilityJanet H Ford, David W Ayer, Qi Zhang, et al.
The Journal of Headache and Pain|November 8, 2023
Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International StudyRichard B Lipton, Michel Lanteri-Minet, Elizabeth Leroux, et al.
Cephalalgia : an International Journal of Headache|August 23, 2024
Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) StudyZaza Katsarava, Dawn C Buse, Elizabeth Leroux, et al.
Pageof 3